Blog
Featured post
Advancing maternal and pediatric research with the largest and most complete mother and child EHR dataset
Truveta wins 2024 Stevie Awards for Most Innovative Company and Achievement in Technology
Truveta was named winner of a Gold Stevie® Award for Achievement in Science or Technology, as well as a Silver for Most Innovative Company of the Year in the 22nd Annual American...
Advancing maternal and pediatric research with the largest and most complete mother and child EHR dataset
Today, we are excited to announce the largest and most complete mother-child electronic health record (EHR) dataset for scientifically rigorous research on mothers and their...
Our journey of applying generative AI to advance healthcare
Truveta recently won the SXSW Innovation Award for Artificial Intelligence, which recognized the groundbreaking work we have been doing to apply modern generative AI technology...
Ending the HIV epidemic: Finding new insights with EHR data
In 2019, the US government unveiled the ambitious Ending the HIV Epidemic (EHE) plan, aiming to slash new HIV infections by 90% by 2030. Thanks to advances in antiretroviral...
Real-time monitoring of respiratory virus-associated hospitalizations: Trends from October 2019 through March 2024
Overall, the rate of hospitalizations associated with respiratory viruses has decreased throughout March 2024 (-32.4%) compared to February 2024. For infants and children, we see...
Trends in the incidence of syphilis among US adults since 2019
Truveta Research explored the monthly trends in the incidence of syphilis among US adults from January 2019 to December 2023. During the early months of the COVID-19 pandemic,...
Device label expansion using real-world data
US spending on medical devices and in-vitro diagnostics totals more than $199 billion a year, with most of the costs associated with clinical development. Label expansion...
Off-label use of drugs and devices in medical practice
A common misconception is that drugs and devices must gain explicit approval from the FDA for each specific use before healthcare providers can employ them. However, a practice...
The Adderall shortage: Exploring rates of prescription fills over time
There was a decrease in the rate of amphetamine/dextroamphetamine (Adderall) prescription fills per eligible population starting in the fall of 2022; prescription fill rates were...